pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,347 catalysts · 5,347 phase readout · 2,315 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 20 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: drug expiry×type: phase readout×clear all
type
  • phase readout5,347
  • 8k filing2,315
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›ACTIVE_NOT_RECRUITINGphase readoutNCT02693990: A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Meningioma, Brain Tumor

full page →ctgov ↗
›COMPLETEDphase readoutNCT07115160: The Leksand Hockey Trial on Grip Strength

Sponsor: Dalarna County Council, Sweden. Phase: NA. Conditions: Grip Strength, Performance, Injuries

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06218082: Vitiligo Registry for Adults and Children in the UK

Sponsor: The Royal Wolverhampton Hospitals NHS Trust. Phase: . Conditions: Dermatologic Disease, Vitiligo

full page →ctgov ↗
›RECRUITINGphase readoutNCT06041282: Conservative Treatment of Early Adhesive Capsulitis

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: NA. Conditions: Adhesive Capsulitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07408024: Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis

Sponsor: Toll Biotech Co. Ltd. (Beijing). Phase: PHASE2. Conditions: Rheumatoid Arthritis (RA)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07602023: Triglyceride-rich LIPoproteins and INflammatory Cytokines After Oral FAT Loading as Potential Early Biomarkers of the Risk of Progression Towards DIABETES and Development of Complications. LIPINFAT Diabetes Study.

Sponsor: Angelina Passaro. Phase: . Conditions: Prediabetes / Type 2 Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT04393623: Stress, Emotion Regulation, and Alcohol in Women Veterans

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Alcohol Use Disorder, Post Traumatic Stress Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07589023: A Retrospective Review: Outcomes of the REFLECT™ System for Idiopathic Scoliosis

Sponsor: Globus Medical Inc. Phase: . Conditions: Idiopathic Scoliosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT04569123: Concomitant Sensory Stimulation During Therapy to Enhance Hand Functional Recovery Post Stroke

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Stroke, Physical Disability

full page →ctgov ↗
›RECRUITINGphase readoutNCT07482059: A Multicenter Clinical Study of Combined Therapy for Unresectable Hepatocellular Carcinoma

Sponsor: West China Hospital. Phase: PHASE1. Conditions: Unresectable Hepatocellular Carcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07524296: QTc Interval in Cesarean Section Patients

Sponsor: Haseki Training and Research Hospital. Phase: NA. Conditions: Pregnant Women, Cesarean Birth

full page →ctgov ↗
›COMPLETEDphase readoutNCT07498062: Multimodal Chewing Gum Flavour Training to Aid Flavour Perception Recovery - a Pilot Study.

Sponsor: University of Nottingham. Phase: NA. Conditions: Anosmia, Parosmia, Phantosmia, Dysgeusia, Ageusia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07262788: A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 Diabetes

Sponsor: Steno Diabetes Center Copenhagen. Phase: NA. Conditions: Type 2 Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT07491003: Laparoscopic Hiatal Hernia Repair With Mesh Cruroplasty

Sponsor: Zagazig University. Phase: NA. Conditions: Hiatal Hernia, Sleeve Gastrectomy

full page →ctgov ↗
›RECRUITINGphase readoutNCT06854627: Effect of Continuous Prolonged Prone Position Versus Intermittent Daily Prone Position in ARDS

Sponsor: Pontificia Universidad Catolica de Chile. Phase: NA. Conditions: Acute Respiratory Distress Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07076342: The Role of mGluR5 in CBT-I

Sponsor: Stony Brook University. Phase: PHASE4. Conditions: Major Depressive Disorder (MDD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06693986: Adenovirus (RGDCRAdCOX2F)

Sponsor: Masonic Cancer Center, University of Minnesota. Phase: PHASE1. Conditions: Adenocarcinoma of Pancreas

full page →ctgov ↗
›AVAILABLEphase readoutNCT03773770: Expanded Access to Triheptanoin

Sponsor: Ultragenyx Pharmaceutical Inc. Phase: . Conditions: Long Chain Fatty Acid Oxidation Disorders

full page →ctgov ↗
›WITHDRAWNphase readoutNCT06648473: Repeatability of Magnetic Resonance Imaging in Patients With IDH1 Mutant Glioma on Ivosidenib

Sponsor: Duke University. Phase: NA. Conditions: Low Grade Glioma of Brain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07251673: Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Dravet Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT06854367: Accelerated vs. Conventional Theta Burst Stimulation for Late-life Depression

Sponsor: Centre for Addiction and Mental Health. Phase: NA. Conditions: Late Life Depression (LLD), Depression - Major Depressive Disorder, Depressive Disorder, Treatment-Resistant, Mood Disorders

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03796767: Salvage Oligometastasectomy and Radiation Therapy in Recurrent Prostate Cancer

Sponsor: University of Utah. Phase: PHASE2. Conditions: Recurrent Prostate Carcinoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lymph Nodes, Oligometastasis, Prostate Adenocarcinoma, PSA Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT00086567: Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

Sponsor: National Cancer Institute (NCI). Phase: . Conditions: Fallopian Tube Cancer, Peritoneal Neoplasms, Epithelial Ovarian Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07179107: Adequate Hydration and Health Outcomes

Sponsor: Arizona State University. Phase: NA. Conditions: Dehydration, Dehydration (Physiology), Glucose Abnormalities, Cardiovascular

full page →ctgov ↗
›RECRUITINGphase readoutNCT07327307: Real World Evidence Study of SYN023 in Children Exposed to Rabies

Sponsor: Synermore Biologics (Suzhou) Co., Ltd.. Phase: . Conditions: Rabies Post-exposure Prophylaxis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07609511: Magnet System Gastric Outlet Obstruction Study

Sponsor: GT Metabolic Solutions, Inc.. Phase: NA. Conditions: Gastric Outlet Obstruction

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06505811: Mixed Methods Evaluation of the Pomona Household Universal Grant (HUG) Program

Sponsor: University of California, Los Angeles. Phase: NA. Conditions: Early Child Well-being, Parental Stress, Family Economic Security, Parental/Caregiver Health, Mental Health

full page →ctgov ↗
›RECRUITINGphase readoutNCT07407465: Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal Cancer.

Sponsor: Gruppo Oncologico del Nord-Ovest. Phase: PHASE2. Conditions: Colorectal Cancer, Colorectal Adenocarcinoma, Rectal Adenocarcinoma, Rectal Cancer, Adenocarcinoma, Rectal Cancer, Metastatic, Colon Cancer Metastatic, Colon Cancer Adenocarcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06532565: Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors

Sponsor: Gilead Sciences. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT07032467: Social Media Addiction and Compulsive Exercise Behaviors

Sponsor: Saglik Bilimleri Universitesi. Phase: . Conditions: Healthy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06687967: A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)

Sponsor: Sanofi. Phase: PHASE3. Conditions: Lichen Simplex Chronicus

full page →ctgov ↗
›COMPLETEDphase readoutNCT07380607: Double Triggering Asynchrony in Mechanically Ventilated Patients.

Sponsor: Mansoura University. Phase: . Conditions: Respiratory Failure, Critical Illness, Mechanical Ventilation

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07055607: A Two-year Prospective, Observational Study of Wegovy in Real-world Clinical Practice

Sponsor: Novo Nordisk A/S. Phase: . Conditions: Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07576907: Ayre's Sensory-Motor Integration Exercises and Sensory Modulation And Motor Skills In Children With ASD

Sponsor: Riphah International University. Phase: NA. Conditions: Motor Skills Disorders, Sensory Processing Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT04066192: Brexpiprazole in Alcohol Use Disorder

Sponsor: University of Colorado, Denver. Phase: PHASE2. Conditions: Alcohol Use Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07394192: Short-Course Radiotherapy With Tumor-Draining Lymph Node Preservation Followed by PD-1 Inhibitors in pMMR/MSS Stage II-III Rectal Cancer

Sponsor: Peking University Cancer Hospital & Institute. Phase: PHASE2. Conditions: Rectal Cancer, Radiotherapy, PD-1 Inhibitor

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07480811: The Effect of the DASH Diet on Clinical and Metabolic Parameters in Children With MASLD

Sponsor: Antalya Training and Research Hospital. Phase: NA. Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07445607: "Mulligan Technique vs Phonophoresis With Chitosan for Patellofemoral Pain"

Sponsor: Ahram Canadian University. Phase: NA. Conditions: Patellofemoral Pain Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07331207: The Effect of 3D Printed Framework Bone-Borne Rapid Maxillary Expander in Young Adults

Sponsor: Mansoura University. Phase: NA. Conditions: Bone Anchored Miniscrew Assisted Rapid Palatal Expansion

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07569536: Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock

Sponsor: Hospices Civils de Lyon. Phase: PHASE3. Conditions: Septic Shock, Vasopressor Resistance

full page →ctgov ↗
›RECRUITINGphase readoutNCT06210711: Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center

Sponsor: Baylor Research Institute. Phase: NA. Conditions: Traumatic Injury, PTSD, Posttraumatic Stress Disorder

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07595211: Apically Positioned Flap vs Rolled Flap for Soft Tissue Management During Implant Second-Stage Surgery

Sponsor: Ohio State University. Phase: NA. Conditions: Dental Implant

full page →ctgov ↗
›RECRUITINGphase readoutNCT07462611: HIV Pre-Exposure Prophylaxis (PrEP) Linkage With Immediate Medications in the Emergency Department Study

Sponsor: University of Texas Southwestern Medical Center. Phase: NA. Conditions: HIV Pre-exposure Prophylaxis, PrEP

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07557511: Transcutaneous Electrical Nerve Stimulation Versus Repetitive Transcranial Magnetic Stimulation on Pain and Functional Outcome in Cervical Radiculopathy

Sponsor: Cairo University. Phase: NA. Conditions: Cervical Radiculopathy

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04530565: Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07540507: Data Collection of the TUVA BX and iCover Stent Grafts Implanted During Branched Endovascular Aortic Repair (BEVAR)

Sponsor: JOTEC GmbH. Phase: . Conditions: TAAA, AAA - Abdominal Aortic Aneurysm

full page →ctgov ↗
›COMPLETEDphase readoutNCT07512492: Combination Effect of Proprioceptive Training and Transcranial Magnetic Stimulation on Selected Gait Kinematic Parameters in Stroke Patients

Sponsor: Cairo University. Phase: NA. Conditions: Transcranial Magnetic Stimulation, Stroke, Gait Disorders, Neurologic, Proprioceptive Training

full page →ctgov ↗
›COMPLETEDphase readoutNCT07502092: Mindfulness in Motion Targeted to Sustaining the Mental and Physical Resilience of First Responders

Sponsor: Ohio State University. Phase: NA. Conditions: Stress, Resilience and Mental Health of First Responders, Work Engagement, Musculoskeletal Discomfort, First Responders

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07533292: Bacteriophage Therapy for Orthopedic Implant-Associated Infections

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: PHASE3. Conditions: Orthopedic, Implant Infection

full page →ctgov ↗
›RECRUITINGphase readoutNCT04732065: ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Sponsor: Sabine Mueller, MD, PhD. Phase: PHASE1. Conditions: Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma, Recurrent Malignant Central Nervous System Neoplasm, Spinal Cord Glioma, World Health Organization (WHO) Grade III Glioma, CNS Tumor, Central Nervous System Tumor

full page →ctgov ↗
← prev
page 48 of 107
next →